摘要
Hurdles exist to clinical xenotransplantation including potential infectious transmission from nonhuman species to xenograft recipients. In anticipation of clinical trials of xenotransplantation, the associated infectious risks have been investigated. Swine and immunocompromised humans share some potential pathogens. Swine herpesviruses including porcine cytomegalovirus (PCMV) and porcine lymphotropic herpesvirus (PLHV) are largely species-specific and do not, generally, infect human cells. Human cellular receptors exist for porcine endogenous retrovirus (PERV), which infects certain human-derived cell lines in vitro. PERV-inactivated pigs have been produced recently. Human infection due to PERV has not been described. A screening paradigm can be applied to exclude potential human pathogens from "designated pathogen free" breeding colonies. Various microbiological assays have been developed for screening and diagnosis including antibody-based tests and qualitative and quantitative molecular assays for viruses. Additional assays may be required to diagnose pig-specific organisms in human xenograft recipients. Significant progress has been made in the evaluation of the potential infectious risks of clinical xenotransplantation. Infectious risk would be amplified by intensive immunosuppression. The available data suggest that risks of xenotransplant-associated recipient infection are manageable and that clinical trials can be performed safely. Possible infectious risks of xenotransplantation to the community at large are undefined but merit consideration. Hurdles exist to clinical xenotransplantation including potential infectious transmission from nonhuman species to xenograft recipients. In anticipation of clinical trials of xenotransplantation, the associated infectious risks have been investigated. Swine and immunocompromised humans share some potential pathogens. Swine herpesviruses including porcine cytomegalovirus (PCMV) and porcine lymphotropic herpesvirus (PLHV) are largely species-specific and do not, generally, infect human cells. Human cellular receptors exist for porcine endogenous retrovirus (PERV), which infects certain human-derived cell lines in vitro. PERV-inactivated pigs have been produced recently. Human infection due to PERV has not been described. A screening paradigm can be applied to exclude potential human pathogens from "designated pathogen free" breeding colonies. Various microbiological assays have been developed for screening and diagnosis including antibody-based tests and qualitative and quantitative molecular assays for viruses. Additional assays may be required to diagnose pig-specific organisms in human xenograft recipients. Significant progress has been made in the evaluation of the potential infectious risks of clinical xenotransplantation. Infectious risk would be amplified by intensive immunosuppression. The available data suggest that risks of xenotransplant-associated recipient infection are manageable and that clinical trials can be performed safely. Possible infectious risks of xenotransplantation to the community at large are undefined but merit consideration. Xenotransplantation, the transplantation of viable cells, organs, or tissues between species, is proposed as a solution to the shortage of human organs for the treatment of organ failure. Recent advances in the management of immunological and metabolic barriers to pig-to-primate xenotransplantation improve the likelihood that clinical trials of xenotransplantation are feasible. The risk of infection in xenotransplantation due to organisms derived from nonhuman source animal species remains an important, and ill-defined, challenge to clinical xenotransplantation. As for all hosts, the risk for infection in the recipient after transplantation reflects the interaction between 2 factors: the epidemiology of infection including the dose, intensity, and virulence of the specific organisms present in the recipient and the graft; and the "net state of immunosuppression"—a conceptual measure of any factors that may contribute to the risk for active infection, such as the intensity and duration of immunosuppression.1Fishman JA Infection in solid-organ transplant recipients.New England J Med. 2007; 357: 2601-2614Crossref PubMed Scopus (1382) Google Scholar,2Fishman JA Infection in organ transplantation.Am J Transplant. 2017; 17: 856-879Abstract Full Text Full Text PDF PubMed Scopus (349) Google Scholar The transmission of infection with viable cells and tissues is efficient, notably for intracellular organisms and latent viruses, and is enhanced by the immunosuppression required to prevent graft rejection. Some of the earliest discussions of unexpected, donor-derived infections in transplantation surrounded xenotransplantation.3Grossi PA Fishman JA Donor-derived infections in solid organ transplant recipients.Am J Transplant. 2009; 9: S19-S26Abstract Full Text Full Text PDF PubMed Scopus (72) Google Scholar, 4Fishman JA Grossi PA Donor-derived infection–the challenge for transplant safety.Nat Rev Nephrol. 2014; 10: 663-672Crossref PubMed Scopus (52) Google Scholar, 5Fishman JA Xenosis and xenotransplantation: addressing the infectious risks posed by an emerging technology.Kidney Int—Suppl. 1997; 58: S41-S45PubMed Google Scholar In human allotransplantation, donor screening is used as a basis for decisions regarding donor suitability and for prophylactic or therapeutic interventions in recipients. It is understood that a risk for disease transmission exists in all forms of transplantation. Some common infectious transmissions are considered "acceptable" based on the availability of prophylactic therapies, including cytomegalovirus (CMV), Epstein-Barr virus (EBV), herpes simplex virus (HSV), varicella zoster virus (VZV), and recently, hepatitis B virus (HBV), hepatitis C virus (HCV), and HIV (under institutional review board–approved protocols). Reported, unexpected, donor-derived infections occur in approximately 0.2% of transplants in the United States including organisms undetected in donor screening.6Ison MG The epidemiology and prevention of donor-derived infections.Adv Chronic Kidney Dis. 2009; 16: 234-241Abstract Full Text Full Text PDF PubMed Scopus (21) Google Scholar Based on the limited time available to procure and allocate organs from deceased donors, screening data from organ donors available prior to transplantation is generally limited to a panel of serologic and molecular tests; data from blood and urine (and bronchoscopic samples from lung donors) cultures (potentially while receiving antimicrobial therapy) are delayed. Any specialized tests (eg, Strongyloides serologies) are not available until after the organs have been implanted. Despite these limitations, the rate of transmission of infection from human organ donors is very low. The evaluation and exclusion of potential organ donors is considered in the context of the shortage of organs for transplantation. Organs are increasingly used from donors considered at "Increased Risk for the Transmission of Infectious Disease" under US Public Health Service (PHS) Guidelines targeting transmission of HIV, HBV, and HCV.7Phs US PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.Public Health Rep. 2013; 128: 247-343Crossref PubMed Scopus (163) Google Scholar Microbiologic testing of donors including serologic and nucleic acid testing (NAT) and effective treatment options for HIV, HCV, and HBV have allowed use of "PHS increased risk donor" organs.2Fishman JA Infection in organ transplantation.Am J Transplant. 2017; 17: 856-879Abstract Full Text Full Text PDF PubMed Scopus (349) Google Scholar,4Fishman JA Grossi PA Donor-derived infection–the challenge for transplant safety.Nat Rev Nephrol. 2014; 10: 663-672Crossref PubMed Scopus (52) Google Scholar Transplant programs utilizing "increased risk" organs are required by the Centers for Medicare & Medicaid Services (CMS) Guidelines and Organ Procurement and Transplant Network (OPTN) Policies to obtain informed consent from the patient prior to transplantation and to offer follow-up testing for HIV, HCV, and HBV. Organ donation from increased risk donors has resulted in few transmission events—the exception being potential donors with negative serologic and molecular viral assays for HIV, HCV, or HBV, likely in the "window period" immediately following viral infection.8Irwin L Kotton CN Elias N et al.Utilization of increased risk for transmission of infectious disease donor organs in solid organ transplantation: retrospective analysis of disease transmission and safety.Transplant Infectious Dis. 2017; 19 (http://doi.org/10.1111/tid.12791)Crossref PubMed Scopus (18) Google Scholar The individual with organ failure may interpret the degree of "risk" with informed consent differently than public health authorities, infectious disease specialists, and transplant physicians and surgeons. The terms "xenosis," "direct zoonosis," and "xenozoonosis" were coined to reflect the unique epidemiology of infection due to organisms potentially carried by nonhuman tissues. Experience with immunocompromised individuals suggests that certain types of pathogens are likely to emerge after transplantation (reviewed in1Fishman JA Infection in solid-organ transplant recipients.New England J Med. 2007; 357: 2601-2614Crossref PubMed Scopus (1382) Google Scholar,5Fishman JA Xenosis and xenotransplantation: addressing the infectious risks posed by an emerging technology.Kidney Int—Suppl. 1997; 58: S41-S45PubMed Google Scholar,9Fishman J Patience C Xenotransplantation: infectious risk revisited.Am J Transplantation. 2004; 4: 1383-1390Abstract Full Text Full Text PDF PubMed Scopus (165) Google Scholar,10Fishman JA Infection in xenotransplantation.J Card Surg. 2001; 16: 363-373Crossref PubMed Scopus (36) Google Scholar) (Table 1). With transplant immunosuppression, both common pathogens of transplant recipients and unique porcine pathogens may emerge. Studies of xenotransplantation recipients and humans with exposure to pigs or pig products have not revealed any consistent patterns of infection. Early preclinical studies focused on the risk of infection when using miniature swine as xenograft donors for immunosuppressed nonhuman primates. Swine were found to be colonized by Actinomyces sp. and Streptococcus suis (J. Fishman, unpublished data) but otherwise had readily identified bacteria as the etiology of line-related bacteremia, pneumonia, or infections related to surgical procedures. The rate of antimicrobial-resistant infection in immunosuppressed recipients of porcine allografts and xenografts (baboons) was reduced through minimization of routine antimicrobial (first-generation cephalosporin surgical perioperative) prophylaxis in both the donor herd and in recipients. Isolation of resistant (fluoroquinolone and cephalosporin) bacteria is reduced by careful attention to routine antibiotic use in pig rearing. Intravenous ganciclovir was used for posttransplant prophylaxis against both porcine cytomegalovirus (PCMV) and baboon cytomegalovirus (BCMV).11Mueller N Sulling K Gollackner B et al.Reduced efficacy of ganciclovir against porcine and baboon cytomegalovirus in pig-to-baboon xenotransplantation.Am J Transplantation. 2003; 3: 1057-1064Crossref PubMed Scopus (48) Google Scholar,12Mueller NJ Barth RN Yamamoto S et al.Activation of cytomegalovirus in pig-to-primate organ xenotransplantation.J Virol. 2002; 76: 4734-4740Crossref PubMed Scopus (101) Google ScholarTABLE 1Considerations in the microbiologic screening of swine as human xenograft donorsSwine organism typeExamplesMicrobiologic assays available?CommentsPathogens of normal humansInfluenza virus, Mycobacterium tuberculosis, Rabies, Mycoplasma spp.YesExclusion based on specific organismPathogens of human transplant recipientsToxoplasma gondii, Strongyloides stercoralis, parvovirusYesExclusion based on specific organismSimilar to common pathogens of human transplant recipientsPorcine cytomegalovirus, porcine lymphotropic herpesvirus, porcine adenovirusSomeValidated assays for human samples required; herpesviruses generally species-specific (see text)Unique swine pathogensPorcine endogenous retrovirus (PERV)FewUnknown risk for humans, validated assays for human samples required Open table in a new tab As for deceased donor screening, the goal of animal husbandry for xenotransplantation is to exclude potential pathogens for the human recipient and to prevent the introduction of new pathogens into breeding colonies from the environment and by care providers. It seems likely that the way in which the level of safety is achieved need not be uniform so long as the transplanted tissues do not pose a microbiologic hazard to the recipient. A potential benefit of xenotransplantation is that the screening paradigm can be more intensive than that used for human organ donors, limited only by the availability of microbiologic assays. Assays may be applied to an isolated herd of donor animals and/or to individual source animals. Validated assays for organisms in swine are largely limited to serologic testing, microscopic examination (stool, parasites), and standard microbiologic cultures for common pathogens, available in a small number of commercial or veterinary laboratories. Other assays (eg, nucleic acid testing for viruses) are more limited. Microbiological standards for pig husbandry should be considered "dynamic"—subject to revision based on experimental and clinical data and reflecting the evolution of testing strategies. Based on experience, 2 separate lists of organisms may facilitate development of swine for xenotransplantation. One group of pathogens is excluded from breeding herds as a measure of pig health status. This list is guided by standard veterinary practice, including routine vaccines with the addition of microbially restricted and mammalian protein-free diets, filtered water, and special housing. Swine for xenotransplantation can be bred in "biosecure facilities" to prevent introduction of potential pig or human pathogens, isolated from other swine and animals, including rodents and birds, often with care providers gowned and gloved. Routine antimicrobial use should be restricted. It is not generally considered useful to develop gnotobiotic swine, which grow less well than swine with normal microbial complements. Genetic modification of swine to reduce graft rejection or for the elimination of endogenous retroviruses necessitates transgenic methods with nuclear transfer in sterile environments and subsequent embryo transfer to surrogate gilts.13Klymiuk N Aigner B Brem G Wolf E Genetic modification of pigs as organ donors for xenotransplantation.Mol Reprod Dev. 2010; 77: 209-221Crossref PubMed Scopus (134) Google Scholar, 14Hryhorowicz M Zeyland J Słomski R Lipiński D Genetically modified pigs as organ donors for xenotransplantation.Mol Biotechnol. 2017; 59: 435-444Crossref PubMed Scopus (63) Google Scholar, 15Yang L Guell M Niu D et al.Genome-wide inactivation of porcine endogenous retroviruses (PERVs).Science. 2015; 350: 1101-1104Crossref PubMed Scopus (402) Google Scholar, 16Sachs DH Galli C Genetic manipulation in pigs.Curr Opin Organ Transplant. 2009; 14: 148-153Crossref PubMed Scopus (44) Google Scholar, 17Phelps CJ Koike C Vaught TD et al.Production of alpha 1,3-galactosyltransferase-deficient pigs.Science. 2003; 299: 411-414Crossref PubMed Scopus (902) Google Scholar A second list of potential swine-derived organisms was created to identify potential pathogens based on experience with immunosuppressed human allotransplant recipients and pig-to-primate xenotransplantation (Table 2). Exclusion, to the degree possible, of these potential pathogens was termed "designated pathogen free" status.5Fishman JA Xenosis and xenotransplantation: addressing the infectious risks posed by an emerging technology.Kidney Int—Suppl. 1997; 58: S41-S45PubMed Google Scholar,9Fishman J Patience C Xenotransplantation: infectious risk revisited.Am J Transplantation. 2004; 4: 1383-1390Abstract Full Text Full Text PDF PubMed Scopus (165) Google Scholar,10Fishman JA Infection in xenotransplantation.J Card Surg. 2001; 16: 363-373Crossref PubMed Scopus (36) Google Scholar,18Fishman JA Infection and xenotransplantation. Developing strategies to minimize risk.Ann N Y Acad Sci. 1998; 862: 52-66Crossref PubMed Scopus (46) Google Scholar,19Fishman JA The risk of infection in xenotransplantation. Introduction.Ann N Y Acad Sci. 1998; 862: 45-51Crossref PubMed Scopus (15) Google Scholar Pig-derived infections in immunosuppressed humans have not been reported with the possible exception of hepatitis E virus (HEV).TABLE 2"Designated-pathogen-free" swineaFor xenotransplantation of solid organs and hematopoietic tissues, listed pathogens may be considered in the development of a screening program for source animals (modified from refs.5,9,10,18,19).Bacteria (exclude animals with infections due to these organisms) :Brucella suisLeptospira spp.Listeria monocytogenesNontuberculous mycobacteria (including Mycobacterium bovis)Mycobacterium tuberculosisMycoplasma hyopneumoniae (lung transplant)Salmonella spp. (typhi, typhimurium, choleraesuis)ShigellaStool enteric pathogens (Yersinia, Campylobacter)Fungi (exclude animals with infections due to):Aspergillus species (colonized or lesions)Candida species (lesions)Cryptococcus neoformansHistoplasma capsulatumParasites (stool exam or serology):Ascaris suumCryptosporidium/Microsporidium spp.Echinococcus spp.Giardia spp.Isospora sp.,Strongyloides speciesToxoplasma gondiiTrichinella spiralisTrypanosoma spp.Viruses:Adenovirus of swine (active infection)Encephalomyocarditis virus (vaccine)Hepatitis E virusInfluenza virus (swine and human)Porcine cytomegalovirusPorcine circovirus (1, 2)Porcine lymphotropic herpesvirusPorcine reproductive and respiratory syndrome virusPorcine parvovirusPseudorabies virusRabies virusa For xenotransplantation of solid organs and hematopoietic tissues, listed pathogens may be considered in the development of a screening program for source animals (modified from refs.5Fishman JA Xenosis and xenotransplantation: addressing the infectious risks posed by an emerging technology.Kidney Int—Suppl. 1997; 58: S41-S45PubMed Google Scholar,9Fishman J Patience C Xenotransplantation: infectious risk revisited.Am J Transplantation. 2004; 4: 1383-1390Abstract Full Text Full Text PDF PubMed Scopus (165) Google Scholar,10Fishman JA Infection in xenotransplantation.J Card Surg. 2001; 16: 363-373Crossref PubMed Scopus (36) Google Scholar,18Fishman JA Infection and xenotransplantation. Developing strategies to minimize risk.Ann N Y Acad Sci. 1998; 862: 52-66Crossref PubMed Scopus (46) Google Scholar,19Fishman JA The risk of infection in xenotransplantation. Introduction.Ann N Y Acad Sci. 1998; 862: 45-51Crossref PubMed Scopus (15) Google Scholar). Open table in a new tab Viral infection is common after organ transplantation due to the efficient transmission of viruses with viable cells and suppression of T lymphocyte–mediated antiviral immune responses in the MHC-disparate graft. Multiple factors increase viral replication subsequently including immunosuppression, graft rejection, proinflammatory cytokines, and ischemia-reperfusion injury. In xenotransplantation, these factors may also contribute to replication of porcine endogenous retrovirus (PERV), porcine cytomegalovirus (PCMV) and porcine lymphotropic herpesvirus (PLHV-1, -2, -3). Additional infections observed in immunosuppressed swine, as well as normal animals, include porcine circovirus (PCV) and adenovirus. The diagnosis of infections due to these common porcine organisms in primate recipients has been addressed by the development of sensitive, quantitative NAT assays for PERV, PLHV, PCMV, and PCV. Each virus is associated with a specific clinical syndrome in swine and in nonhuman primate xenograft recipients. PCMV causes infection restricted to the porcine renal xenografts with endothelial activation, consumptive coagulopathy, and early graft loss.12Mueller NJ Barth RN Yamamoto S et al.Activation of cytomegalovirus in pig-to-primate organ xenotransplantation.J Virol. 2002; 76: 4734-4740Crossref PubMed Scopus (101) Google Scholar,20Mueller NJ Kuwaki K Dor FJMF et al.Reduction of consumptive coagulopathy using porcine cytomegalovirus-free cardiac porcine grafts in pig-to-primate xenotransplantation.Transplantation. 2004; 78: 1449-1453Crossref PubMed Scopus (65) Google Scholar, 21Gollackner B Mueller NJ Houser S et al.Porcine cytomegalovirus and coagulopathy in pig-to-primate xenotransplantation.Transplantation. 2003; 75: 1841-1847Crossref PubMed Scopus (74) Google Scholar, 22Yamada K Tasaki M Sekijima M et al.Porcine cytomegalovirus infection is associated with early rejection of kidney grafts in a pig to baboon xenotransplantation model.Transplantation. 2014; 98: 411-418Crossref PubMed Scopus (0) Google Scholar, 23Sekijima M Waki S Sahara H et al.Results of life-supporting galactosyltransferase knockout kidneys in cynomolgus monkeys using two different sources of galactosyltransferase knockout Swine.Transplantation. 2014; 98: 419-426Crossref PubMed Scopus (42) Google Scholar PCMV can be excluded from pig colonies by early weaning and careful isolation.24Clark DA Fryer JF Tucker AW et al.Porcine cytomegalovirus in pigs being bred for xenograft organs: progress towards control.Xenotransplantation. 2003; 10: 142-148Crossref PubMed Scopus (52) Google Scholar, 25Mueller NJ Kuwaki K Knosalla C et al.Early weaning of piglets fails to exclude porcine lymphotropic herpesvirus.Xenotransplantation. 2005; 12: 59-62Crossref PubMed Scopus (49) Google Scholar, 26Edington N Broad S Wrathall AE Done JT Superinfection with porcine cytomegalovirus initiating transplacental infection.Vet Microbiol. 1988; 16: 189-193Crossref PubMed Scopus (24) Google Scholar, 27Tucker AW Galbraith D McEwan P Onions D Evaluation of porcine cytomegalovirus as a potential zoonotic agent in xenotransplantation.Transplant Proc. 1999; 31: 915Crossref PubMed Scopus (40) Google Scholar PLHV has been associated with a form of posttransplantation lymphoproliferative disorder (PTLD) in immunosuppressed swine undergoing stem cell transplantation.28Dor FJ Doucette KE Mueller NJ et al.Posttransplant lymphoproliferative disease after allogeneic transplantation of the spleen in miniature swine.Transplantation. 2004; 78: 286-291Crossref PubMed Scopus (22) Google Scholar,29Doucette K Dor FJ Wilkinson RA et al.Gene expression of porcine lymphotrophic herpesvirus-1 in miniature Swine with posttransplant lymphoproliferative disorder.Transplantation. 2007; 83: 87-90Crossref PubMed Scopus (20) Google Scholar Porcine herpesviruses appear to be relatively species-specific; active graft infection is not associated with systemic infection in primate recipients of xenografts, although shed virus may be detected in circulation.27Tucker AW Galbraith D McEwan P Onions D Evaluation of porcine cytomegalovirus as a potential zoonotic agent in xenotransplantation.Transplant Proc. 1999; 31: 915Crossref PubMed Scopus (40) Google Scholar,30Whitteker JL Dudani AK Tackaberry ES Human fibroblasts are permissive for porcine cytomegalovirus in vitro.Transplantation. 2008; 86: 155-162Crossref PubMed Scopus (30) Google Scholar Other viral infections tend to be self-limited in normal swine. Porcine circovirus type 2 (PCV2), for example, may cause pneumonia and wasting syndrome and depresses various innate immune functions.31Richmond O Cecere TE Erdogan E et al.PD-L1 expression is increased in monocyte derived dendritic cells in response to porcine circovirus type 2 and porcine reproductive and respiratory syndrome virus infections.Vet Immunol Immunopathol. 2015; 168: 24-29Crossref PubMed Scopus (13) Google Scholar,32Kekarainen T Montoya M Mateu E Segales J Porcine circovirus type 2-induced interleukin-10 modulates recall antigen responses.J Gen Virol. 2008; 89: 760-765Crossref PubMed Scopus (62) Google Scholar Transmission of these viruses to human hosts has not been reported. The isolation and sequencing of PERV was based on early studies of a retrovirus associated with swine lymphoma.33Lieber MM Sherr CJ Benveniste RE Todaro GJ Biologic and immunologic properties of porcine type C viruses.Virology. 1975; 66: 616-619Crossref PubMed Scopus (65) Google Scholar, 34Suzuka I Sekiguchi K Kodama M Some characteristics of a porcine retrovirus from a cell line derived from swine malignant lymphomas.FEBS Lett. 1985; 183: 124-128Crossref PubMed Scopus (27) Google Scholar, 35Suzuka I Shimizu N Sekiguchi K Hoshino H Kodama M Shimotohno K Molecular cloning of unintegrated closed circular DNA of porcine retrovirus.FEBS Lett. 1986; 198: 339-343Crossref PubMed Scopus (33) Google Scholar, 36Todaro GJ Benveniste RE Lieber MM Sherr CJ Characterization of a type C virus released from the porcine cell line PK(15).Virology. 1974; 58: 65-74Crossref PubMed Scopus (94) Google Scholar, 37Patience C Takeuchi Y Weiss RA Infection of human cells by an endogenous retrovirus of pigs. [see comment].Nat Med. 1997; 3: 282-286Crossref PubMed Scopus (1015) Google Scholar, 38Patience C Takeuchi Y Weiss RA Zoonosis in xenotransplantation.Curr Opin Immunol. 1998; 10: 539-542Crossref PubMed Scopus (63) Google Scholar, 39Martin U Winkler ME Id M et al.Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV).Xenotransplantation. 2000; 7: 138-142Crossref PubMed Scopus (134) Google Scholar, 40Akiyoshi DE Denaro M Zhu H Greenstein JL Banerjee P Fishman JA Identification of a full-length cDNA for an endogenous retrovirus of miniature swine.J Virol. 1998; 72: 4503-4507Crossref PubMed Google Scholar, 41Armstrong JA Porterfield JS De Madrid AT C-type virus particles in pig kidney cell lines.J Gen Virol. 1971; 10: 195-198Crossref PubMed Scopus (109) Google Scholar, 42Breese Jr, SS Virus-like particles occurring in cultures of stable pig kidney cell lines. Brief Report.Arch Gesamte Virusforsch. 1970; 30: 401-404Crossref PubMed Scopus (37) Google Scholar Concern about retroviral transmission in xenotransplantation relates to the potential for "silent" transmission or asymptomatic infection with insertional effects and altered gene regulation or oncogenesis. Three closely related C-type porcine endogenous retroviruses (PERV A, B, C) have been identified in swine that possess infectious potential.37Patience C Takeuchi Y Weiss RA Infection of human cells by an endogenous retrovirus of pigs. [see comment].Nat Med. 1997; 3: 282-286Crossref PubMed Scopus (1015) Google Scholar,40Akiyoshi DE Denaro M Zhu H Greenstein JL Banerjee P Fishman JA Identification of a full-length cDNA for an endogenous retrovirus of miniature swine.J Virol. 1998; 72: 4503-4507Crossref PubMed Google Scholar,43Ericsson TA Takeuchi Y Templin C et al.Identification of receptors for pig endogenous retrovirus.Proc Natl Acad Sci USA. 2003; 100: 6759-6764Crossref PubMed Scopus (121) Google Scholar, 44Oldmixon BA Wood JC Ericsson TA et al.Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine.J Virol. 2002; 76: 3045-3048Crossref PubMed Scopus (169) Google Scholar, 45Klymiuk N Muller M Brem G Aigner B Recombination analysis of human-tropic porcine endogenous retroviruses.J Gen Virol. 2003; 84: 2729-2734Crossref PubMed Scopus (13) Google Scholar, 46Klymiuk N Muller M Brem G Aigner B Characterization of porcine endogenous retrovirus gamma pro-pol nucleotide sequences.J Virol. 2002; 76: 11738-11743Crossref PubMed Scopus (36) Google Scholar Human cellular receptors for PERV-A, Human porcine endogenous retrovirus receptor (HuPAR)-1 and HuPAR-2, have been identified.43Ericsson TA Takeuchi Y Templin C et al.Identification of receptors for pig endogenous retrovirus.Proc Natl Acad Sci USA. 2003; 100: 6759-6764Crossref PubMed Scopus (121) Google Scholar PERV-A and -B, can infect human and pig cells in vitro, the third sub-group, PERV-C, infects only pig cells.37Patience C Takeuchi Y Weiss RA Infection of human cells by an endogenous retrovirus of pigs. [see comment].Nat Med. 1997; 3: 282-286Crossref PubMed Scopus (1015) Google Scholar,39Martin U Winkler ME Id M et al.Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV).Xenotransplantation. 2000; 7: 138-142Crossref PubMed Scopus (134) Google Scholar,40Akiyoshi DE Denaro M Zhu H Greenstein JL Banerjee P Fishman JA Identification of a full-length cDNA for an endogenous retrovirus of miniature swine.J Virol. 1998; 72: 4503-4507Crossref PubMed Google Scholar,43Ericsson TA Takeuchi Y Templin C et al.Identification of receptors for pig endogenous retrovirus.Proc Natl Acad Sci USA. 2003; 100: 6759-6764Crossref PubMed Scopus (121) Google Scholar,44Oldmixon BA Wood JC Ericsson TA et al.Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine.J Virol. 2002; 76: 3045-3048Crossref PubMed Scopus (169) Google Scholar,46Klymiuk N Muller M Brem G Aigner B Characterization of porcine endogenous retrovirus gamma pro-pol nucleotide sequences.J Virol. 2002; 76: 11738-11743Crossref PubMed Scopus (36) Google Scholar, 47Takeuchi Y Patience C Magre S et al.Host range and interference studies of three classes of pig endogenous retrovirus.J Virol. 1998; 72: 9986-9991Crossref PubMed Google Scholar, 48Wood JC Quinn G Suling KM et al.Identification of exogenous forms of human-tropic porcine endogenous retrovirus in miniature Swine.J Virol. 2004; 78: 2494-2501Crossref PubMed Scopus (114) Google Scholar, 49Tonjes RR Czauderna F Fischer N et al.Molecularly cloned porcine endogenous retroviruses replicate on human cells.Tran